La Financiere de L'Echiquier’s Vertex Pharmaceuticals VRTX Stock Holding History

La Financiere de L'Echiquier’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$370K	Sell	790 -100	-11%	-$43.4K	0.02%	91
2024 Q1	$372K	Sell	890 -100	-10%	-$42.3K	0.02%	91
2023 Q4	$403K	Sell	990 -220	-18%	-$81.3K	0.02%	91
2023 Q3	$421K	Hold	1,210	–	–	0.02%	94
2023 Q2	$426K	Buy	1,210 +410	+51%	+$138K	0.02%	95
2023 Q1	$252K	Buy	+800	New	+$240K	0.01%	93
2021 Q2	–	Sell	-162,983	Closed	-$35M	–	94
2021 Q1	$35M	Buy	162,983 +19,630	+14%	+$4.31M	1.42%	31
2020 Q4	$33.9M	Buy	143,353 +23,655	+20%	+$5.43M	1.61%	27
2020 Q3	$32.6M	Buy	119,698 +110,392	+1,186%	+$30.5M	2.26%	16
2020 Q2	$2.7M	Buy	9,306 +6,145	+194%	+$1.67M	0.21%	45
2020 Q1	$752K	Buy	+3,161	New	+$725K	0.09%	47

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

La Financiere de L'Echiquier's VRTX Position: Q2 2024 in Review

La Financiere de L'Echiquier reduced its Vertex Pharmaceuticals (VRTX) stake by 11% in Q2 2024, selling an estimated $43.4K and leaving 790 shares worth $370K. The position accounts for 0.02% of the portfolio, ranked #91.

La Financiere de L'Echiquier first reported a position in VRTX in Q1 2020 and has held it in 11 quarters since. The position peaked at $35M in Q1 2021. 1,547 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.

La Financiere de L'Echiquier held 790 shares of Vertex Pharmaceuticals worth $370K as of Q2 2024.
La Financiere de L'Echiquier sold 100 Vertex Pharmaceuticals shares in Q2 2024, an estimated $43.4K.
Vertex Pharmaceuticals made up 0.02% of La Financiere de L'Echiquier's portfolio in Q2 2024, its #91 holding.
La Financiere de L'Echiquier first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 11 quarters since.
La Financiere de L'Echiquier's Vertex Pharmaceuticals position peaked at $35M in Q1 2021.
1,547 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.

Based on La Financiere de L'Echiquier's 13F filing for Q2 2024, filed 18 Jul 2024.